Chronic Pain

Data show skeletal muscle relaxant associated with increased risk of fall-related injury (OR 1.28) and all-cause hospitalization (OR 1.11).

Black patients received different opioid prescriptions compared to White patients, even after clinicians were given additional patient-level data.

A new study finds a 2-step chronic pain screening process helped identify patients in primary care with previously undocumented chronic pain.

Data show total amount of patients pre-guideline was 558,175 compared to 532,962 patients after the release of the guideline.

Physicians who performed well on ABIM examination less likely to prescribe opioids for back pain compared to physicians who did not perform well.

Opioid prescription decreased substantially in 2 years following 2016 CDC guideline for prescribing opioids for chronic pain.

A daily opioid dose higher than 90 MME is associated with 3-fold risk increase, compared to 90 MME or lower.

Data show sublingual sufentanil tablets did not affect pain scores, but did benefit patient satisfaction outcomes.

New research over 2 decades shows patients with opioid use disorder are often prescribed opioid analgesic prior to OUD diagnosis, although rates have decreased in recent years.

Management of the painkiller addiction crisis looked optimistic headed into 2020. The pandemic brought a heavy toll to efforts that took years to establish.

Telemedicine visits for opioid use disorder increased from 0.48% in week 1 to 23.53% in week 13 in 2020.

Dr. Tobias Moeller-Bertram discusses how alternative therapies could replace opioids in the future for chronic pain.

An interview with a pain specialist on advancing alternative pain therapy options.

Adamis plans to address agency concerns regarding the naloxone injection application.

The new drug allows for flexible dosing so as to address individual patient needs.

The indication limits the new opioid to clinical setting use—no take-home prescriptions.

Manipulative techniques are not effective for chronic low back pain among relatively young individuals.

The Patient Controller will join a growing list of Abbott digital care products aimed at streamlining the therapeutic experience.

The findings suggest cannabis should be further investigated as an alternative to opioids.

The findings are consistent with previous research about the efficacy of tanezumab for chronic low back pain.

While the opioid epidemic has had a devastating impact on American families, there is some hope that the future is bright.

In the final segment of the series, experts look ahead to how pain management will grow to treat the millions of burdened Americans.

In part 4 of our series, guideline authors and researchers relay the particularities of guiding and regulating the spread of still-necessary painkiller prescriptions.

According to a new report, males and older individuals are more susceptible to fall-related traumatic brain injury deaths.

In part 2, experts discuss how the public health crisis has reached a third decade, and what plans are to combat addiction problems.